We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 223 results
  1. Application of 3D Whole-Brain Texture Analysis and the Feature Selection Method Based on within-Class Scatter in the Classification and Diagnosis of Alzheimer’s Disease

    Background

    Patients with mild cognitive impairment (MCI) are a high-risk group for Alzheimer’s disease (AD). Thus, a reliable prediction of the...

    Ke Zhou, Zhou Liu, ... Ling**g Hu in Therapeutic Innovation & Regulatory Science
    Article 27 March 2022
  2. Effect of Bumetanide Administration on the Pharmacoresistant Seizure to Lamotrigine in Electrical Amygdala Kindled Rats

    In recent decades, 30 – 40 percent of epilepsy patients did not get relief from seizures by antiepileptic medications. In the present study, the...

    Reyhaneh Kheiri, Abbas Kebriaeezadeh, ... Marzieh Khodadadi in Pharmaceutical Chemistry Journal
    Article 19 June 2023
  3. Presynaptic antiseizure medications - basic mechanisms and clues for their rational combinations

    Among clinically highly efficient antiseizure medications (ASMs) there are modifiers of the presynaptic release machinery. Of them, levetiracetam and...

    Ewa K. Czapińska-Ciepiela, Jarogniew Łuszczki, ... Władysław Lasoń in Pharmacological Reports
    Article Open access 22 May 2024
  4. Neuroprotective effect of apelin-13 and other apelin forms—a review

    Neurodegenerative diseases, which occur when neurons begin to deteriorate, affect millions of people worldwide. These age-related disorders are...

    Katarzyna Kamińska, Hubert Borzuta, ... Agnieszka Cudnoch-Jędrzejewska in Pharmacological Reports
    Article 03 April 2024
  5. Cannabidiol attenuates generalized tonic–clonic and suppresses limbic seizures in the genetically epilepsy-prone rats (GEPR-3) strain

    Background

    Cannabidiol (CBD) has been of rapidly growing interest in the epilepsy research field due to its antiseizure properties in preclinical...

    Willian Lazarini-Lopes, Carolina Campos-Rodriguez, ... Patrick A. Forcelli in Pharmacological Reports
    Article 04 October 2022
  6. Magnetic resonance diffusion tensor imaging in psychiatry: a narrative review of its potential role in diagnosis

    Diffusion tensor imaging (DTI) is an imaging technique that uses magnetic resonance. It measures the diffusion of water molecules in tissues, which...

    Piotr Podwalski, Krzysztof Szczygieł, ... Jerzy Samochowiec in Pharmacological Reports
    Article Open access 30 October 2020
  7. Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders

    The blood-brain barrier (BBB) is composed of specific tight junction proteins and transporters expressed on the lining of endothelial cells of the...

    Ajay Uprety, Yeji Kang, Soo Young Kim in Archives of Pharmacal Research
    Article 24 May 2021
  8. Mindfulness meditation and psychedelics: potential synergies and commonalities

    There has been increasing scientific and clinical interest in studying psychedelic and meditation-based interventions in recent years, both in the...

    Paweł Holas, Justyna Kamińska in Pharmacological Reports
    Article Open access 06 November 2023
  9. Effects of N-acetylcysteine and acetyl-l-carnitine on acute PTZ-induced seizures in larval and adult zebrafish

    Background

    Epilepsy is a prevalent neurological disease, affecting approximately 1–2% of the global population. The hallmark of epilepsy is the...

    Rafael Chitolina, Carlos G. Reis, ... Angelo Piato in Pharmacological Reports
    Article 09 October 2023
  10. Role of oxidative stress in epileptogenesis and potential implications for therapy

    In a state of balance between oxidants and antioxidants, free radicals play an advantageous role of “redox messengers”. In a state of oxidative...

    Kinga K. Borowicz-Reutt, Stanisław J. Czuczwar in Pharmacological Reports
    Article Open access 31 August 2020
  11. A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease

    Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the central nervous system (CNS) leading to mental deterioration and...

    Karolina Maciejewska, Kamila Czarnecka, Paweł Szymański in Pharmacological Reports
    Article Open access 13 June 2021
  12. Pro-inflammatory cytokines, but not brain- and extracellular matrix-derived proteins, are increased in the plasma following electrically induced kindling of seizures

    Background

    The aim of the study was to evaluate the brain-derived proteins, extracellular matrix-derived protein and cytokines as potential peripheral...

    Natalia Chmielewska, Piotr Maciejak, ... Janusz Szyndler in Pharmacological Reports
    Article Open access 30 December 2020
  13. Pre-empt aggression in prison and treat precipitating conditions

    Violence significantly affects people in prison. While aggression may be exacerbated by environmental factors, violence may be reduced by early...

    Caroline Fenton, Arnold Lee in Drugs & Therapy Perspectives
    Article 05 May 2021
  14. Structural feature of TRAFs, their related human diseases and therapeutic intervention

    Several studies have been conducted over the years to unravel the structural information on the receptors that bind to tumor necrosis factor...

    Article 10 May 2021
  15. Effects and mechanisms of phthalates’ action on neurological processes and neural health: a literature review

    During the period of mass industrial production of plastic products, the quality of human health has decreased significantly, especially in...

    Henrieta Hlisníková, Ida Petrovičová, ... Alexander Sirotkin in Pharmacological Reports
    Article 18 January 2021
  16. Luteolin for neurodegenerative diseases: a review

    Neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and multiple sclerosis affect millions of people...

    Dunuvilla Kavindi Jayawickreme, Cletus Ekwosi, ... Katarzyna Socała in Pharmacological Reports
    Article Open access 21 June 2024
  17. Cellular, synaptic, and network effects of chemokines in the central nervous system and their implications to behavior

    Accumulating evidence highlights chemokines as key mediators of the bidirectional crosstalk between neurons and glial cells aimed at preserving brain...

    Joanna Ewa Sowa, Krzysztof Tokarski in Pharmacological Reports
    Article Open access 26 August 2021
  18. Clinical significance of fluid biomarkers in Alzheimer’s Disease

    Abstract

    The number of patients with Alzheimer’s Disease (AD) and other types of dementia disorders has drastically increased over the last decades....

    Piotr Lewczuk, Marta Łukaszewicz-Zając, ... Johannes Kornhuber in Pharmacological Reports
    Article Open access 08 May 2020
  19. Long-term vigabatrin treatment modifies pentylenetetrazole-induced seizures in mice: focused on GABA brain concentration

    Background

    The goal of our study was to examine the long-term effect of vigabatrin (VGB), a γ -aminobutyric acid aminotransferase (GABA-AT) inhibitor...

    Mariusz J. Świąder, Katarzyna Świąder, ... Stanisław J. Czuczwar in Pharmacological Reports
    Article Open access 20 December 2019
  20. Effects of curcumin on neurological diseases: focus on astrocytes

    Astrocytes are the most abundant glial cells in the central nervous system, and are important players in both brain injury and neurodegenerative...

    Samira Eghbaliferiz, Faegheh Farhadi, ... Amirhossein Sahebkar in Pharmacological Reports
    Article 27 May 2020
Did you find what you were looking for? Share feedback.